Round Cell Liposarcoma Global Clinical Trials Review, H1, 2015

Round Cell Liposarcoma Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2590CTIDB
  • |
  • Pages: 73
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Round Cell Liposarcoma Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Round Cell Liposarcoma Global Clinical Trials Review, H1, 2015" provides data on the Round Cell Liposarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Round Cell Liposarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Round Cell Liposarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Round Cell Liposarcoma 5

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Five Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Top Countries Contributing to Clinical Trials in Middle East and Africa 12

Top Countries Contributing to Clinical Trials in Central and South America 13

Clinical Trials by G7 Countries: Proportion of Round Cell Liposarcoma to Oncology Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Round Cell Liposarcoma to Oncology Clinical Trials 17

Clinical Trials by Phase in E7 Countries 18

Clinical Trials by Phase 19

In Progress Trials by Phase 20

Clinical Trials by Trial Status 21

Clinical Trials by End Point Status 22

Subjects Recruited Over a Period of Time 23

Clinical Trials by Sponsor Type 24

Prominent Sponsors 25

Top Companies Participating in Round Cell Liposarcoma Therapeutics Clinical Trials 26

Prominent Drugs 27

Clinical Trial Profiles 28

Clinical Trial Overview of Top Companies 28

Johnson & Johnson 28

Clinical Trial Overview of Johnson & Johnson 28

F. Hoffmann-La Roche Ltd. 29

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 29

Eisai Co., Ltd. 30

Clinical Trial Overview of Eisai Co., Ltd. 30

Clinical Trial Overview of Top Institutes / Government 31

Fred Hutchinson Cancer Research Center 31

Clinical Trial Overview of Fred Hutchinson Cancer Research Center 31

European Organization for Research and Treatment of Cancer 32

Clinical Trial Overview of European Organization for Research and Treatment of Cancer 32

Vector Oncology 33

Clinical Trial Overview of Vector Oncology 33

St. Jude Children's Research Hospital 34

Clinical Trial Overview of St. Jude Children's Research Hospital 34

Fondazione IRCCS-Istituto Nazionale dei Tumori 35

Clinical Trial Overview of Fondazione IRCCS-Istituto Nazionale dei Tumori 35

Istituto Nazionale per lo Studio e la Cura dei Tumori 36

Clinical Trial Overview of Istituto Nazionale per lo Studio e la Cura dei Tumori 36

Five Key Clinical Profiles 37

Appendix 71

Abbreviations 71

Definitions 71

Research Methodology 72

Secondary Research 72

About GlobalData 73

Contact Us 73

Disclaimer 73

Source 73

List of Figures

Round Cell Liposarcoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Round Cell Liposarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Round Cell Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Round Cell Liposarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 9

Round Cell Liposarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10

Round Cell Liposarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11

Round Cell Liposarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 13

Proportion of Round Cell Liposarcoma to Oncology Clinical Trials, G7 Countries (%), 2015* 14

Round Cell Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Round Cell Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Round Cell Liposarcoma to Oncology Clinical Trials, E7 Countries (%), 2015* 17

Round Cell Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18

Round Cell Liposarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19

Round Cell Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20

Round Cell Liposarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21

Round Cell Liposarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22

Round Cell Liposarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23

Round Cell Liposarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 24

Round Cell Liposarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25

Round Cell Liposarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26

Round Cell Liposarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27

GlobalData Methodology 72

List of Tables

Round Cell Liposarcoma Therapeutics, Global, Clinical Trials by Region, 2015* 6

Round Cell Liposarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Round Cell Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Round Cell Liposarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 9

Round Cell Liposarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10

Round Cell Liposarcoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 11

Round Cell Liposarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12

Round Cell Liposarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 13

Proportion of Round Cell Liposarcoma to Oncology Clinical Trials, G7 Countries (%), 2015* 14

Round Cell Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Round Cell Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Round Cell Liposarcoma to Oncology Clinical Trials, E7 Countries (%), 2015* 17

Round Cell Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18

Round Cell Liposarcoma Therapeutics, Global, Clinical Trials by Phase, 2015* 19

Round Cell Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20

Round Cell Liposarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21

Round Cell Liposarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22

Round Cell Liposarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23

Round Cell Liposarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 24

Round Cell Liposarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25

Round Cell Liposarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26

Round Cell Liposarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27

Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 28

Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 29

Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 30

Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015* 31

Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 32

Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Vector Oncology, 2015* 33

Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children's Research Hospital, 2015* 34

Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fondazione IRCCS-Istituto Nazionale dei Tumori, 2015* 35

Round Cell Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Nazionale per lo Studio e la Cura dei Tumori, 2015* 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Round Cell Liposarcoma Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Round Cell Liposarcoma, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 162350
Site License
USD 5000 INR 324700
Corporate User License
USD 7500 INR 487050

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com